Abstract
Introduction
Using balloon-expandable stents (BES) for treatment of intracranial stenoses, high inflation pressures and rigidity of the device are regarded as major drawbacks limiting feasibility and safety of the procedure. Self-expanding stents (SES) were developed to facilitate lesion access and to allow for less aggressive dilatation. We analyzed data of the INTRASTENT multicentric registry to assess whether self-expanding stents significantly reduced peri-interventional complication rates.
Methods
Records of intracranial stent procedures were entered consecutively into the registry. Datasets were divided into two groups according to the type of stent used. For outcome measurement, we chose three categories: TIA/minor stroke [modified Rankin score (mRS) <2], disabling stroke, and patient death. Clinical outcome was compared between BES and SES. We analyzed types of adverse events occurring in each group in addition.
Results
Of 409 atherosclerotic lesions, 254 were treated with BES and 155 with SES. Technical success rates were 97.6% and 98.7%, respectively. Adverse event rates were 4.9%, 3.7%, and 0.8% for TIA/nondisabling stroke, disabling stroke, and death in the BES group compared with 5.3%, 6.0%, and 4.0% in the SES group. The differences were not statistically significant. We observed more perforator strokes after use of BES, but thromboembolic events occurred more often in the SES treatment group.
Conclusion
Data of the INTRASTENT registry do not support the hypothesis that introduction of SES lowered the overall complication rate of intracranial stent procedures. There might be an advantage using self-expanding stents in vessel segments with important perforating arteries.
Similar content being viewed by others
References
Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG (2005) Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 352:1305–1316
Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ (2006) Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 113:555–563
Meyers PM, Schumacher CH, Tanji K, Higashida RT, Caplan LR (2007) Use of stents to treat intracranial cerebrovascular disease. Annu Rev Med 58:107–122
Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, Ma N (2007) Comparison of elective stenting of severe versus moderate intracranial atherosclerotic stenosis. Neurology 68:420–426
Vajda Z, Miloslavski E, Güthe T, Schmid E, Schul C, Albes G, Henkes H (2009) Treatment of intracranial atherosclerotic arterial stenoses with a balloon-expandable cobalt chromium stent (Coroflex Blue). Neuroradiology. doi:10.1007/s00234-009-0615-7
Jiang WJ, Xu XT, Jin M, Du B, Dong KH, Dai JP (2007) Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results. Am J Neuroradiol 28:830–834
Lylyk P, Rufenacht D, Ferrario A, Miranda C, Pabon B, Mussachio A, Vila JF, Cohen JE (2005) Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis. Neurol Res 27(Suppl 1):S84–S88
Kurre W, Berkefeld J, Sitzer M, Neumann-Haefelin T, du Mesnil de Rochemont R (2008) Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable pharos stent: initial experience. Neuroradiology 50:701–708
Fiorella D, Chow M, Anderson M, Woo H, Rasmussen PA, Masaryk TJ (2007) A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar atheromatous disease. Neurosurgery 61:236–243
Bose A, Hartmann M, Henkes H, Liu HM, Teng M, Szikora I, Berlis A, Reul J, Yu S, Forsting M, Lui M, Lim W, Po Sit S (2007) A novel self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan Study. Stroke 38:1531–1537
Henkes H, Milosawski E, Lowens S, Reinartz J, Liebig T, Kühne D (2004) Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (wingspan). Neuroradiology 47:222–228
Fiorella D, Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienietz B, Hanel RA, Woo H, Radmussen PA, Hopkins LN, Masaryk TJ, McDougall CG (2007) US multicenter experience with the wingspan stent system for treatment of intracranial atherosclerotic disease—periprocedural results. Stroke 38:881–887
Kurre W, Berkefeld J, Brassel F, Brüning R, Eckert B, Kamek S, Klein GE, Knauth M, Liebig T, Maskova J, Mucha D, Neumann-Haefelin T, Pilgram-Pastor S, Sitzer M, Sonnberger M, Tietke M, Trenkler J, Turowski B, INTRASTENT Study Group (2010) In hospital complication rates after stent treatment of 388 intracranial stenoses—results from the INTRASTENT multicentric registry. Stroke 41:494–498
Berry CC (1990) A tutorial in confidence intervals for proportions in diagnostic radiology. AJR 154:477–480
Mori T, Kazita K, Chokyu K, Mima T, Mori K (2000) Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol 21:249–254
Nahab F, Lynn MJ, Kasner SE, Alexander MJ, Klucznik R, Zaidat OO, Chaloupka J, Lutsep H, Barnwell S, Mawad M, Lane B, Chimowitz MI, NIH Multicenter Wingspan Intracranial Stent Registry Study Group (2009) Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology 72:2014–2019
Jiang WJ, Srivastava T, Gao F, Du B, Dong KH, Xu XT (2006) Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology 66:1868–1872
Müller-Schunk S, Linn J, Peters N, Spannagl M, Deisenberg M, Brückmann H, Mayer TE (2008) Monitoring of clopidogrel-related platelet inhibition: correlation of nonresponse with clinical outcome in supra-aortic stenting. AJNR Am J Neuroradiol 29:786–791
Prabhrakan S, Wells KR, Lee VH, Flaherty CA, Lopes DK (2007) Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting. Am J Neuroradiol 29:281–285
Acknowledgments
We thank the collaborators of the INTRASTENT study group.
In Germany:
From the University of Frankfurt, we thank W. Kurre, J. Berkefeld, M. Sitzer, T. Neumann-Haefelin, and M. Lorenz; from the University of Göttingen, M. Knauth, S. Pilgram-Pastor, R. Schramm, and J.H. Buhk; from AK Altona Hamburg, B. Eckert, A. Leppien; from the Asklepios Klinik Barmbek Hamburg, R. Brüning and T. Fitting; from the University of Hamburg, J. Fiehler and O. Wittkugel; from the University of Düsseldorf, B. Turowski; from the University of Dresden, R. v. Kummer, D. Mucha, and V. Pütz; from the University of Kiel, O. Jansen, and M. Tietke; from Wedau Kliniken Duisburg, F. Brassel, D. Meila, and S. Schotes; from the University of Mainz, W. Müller-Forell; from the University Hospital Rechts der Isar Munich, Th. Liebig, and F. Dorn; from the University of Marburg, I. Kureck; and from Helios Klinikum Erfurt, J. Klisch and V. Sychra.
In Austria:
From Landesnervenklinik Wagner-Jauregg Linz, we thank J. Trenkler, M. Sonnberger, and H.P. Haring; and University of Graz, G.E. Klein, T. Mikolits, K. Niederkorn, and S. Horner.
In Great Britain:
From the University of Oxford, we thank W. Kueker.
In Greece:
From the Papanikolaou General Hospital Thessaloniki, we thank V. Katsaridis.
In Czechoslovakia:
From the Central Military Hospital Prague, we thank J. Maskova and H. Parobkova.
Conflict of interest
W. Kurre has received a modest Speaker's Honoraria from Micrus Endovascular. J. Berkefeld has received modest honoraria as a Consultant of Micrus Endovascular. B. Eckert has received modest Speaker's honoraria from Boston Scientific.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Kurre, W., Brassel, F., Brüning, R. et al. Complication rates using balloon-expandable and self-expanding stents for the treatment of intracranial atherosclerotic stenoses. Neuroradiology 54, 43–50 (2012). https://doi.org/10.1007/s00234-010-0826-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-010-0826-y